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Abstract
The triglyceride glucose (TyG) index is a useful surrogate marker for insulin resistance, which is an important risk factor for coronary
artery disease (CAD). However, data on the relationship of the TyG index and coronary plaque characteristics are limited.
This study included 2840 participants with near-normal renal function who underwent coronary computed tomography
angiography. CAD was deﬁned as the presence of any plaques, and obstructive CAD was deﬁned as the presence of plaques with
≥50% stenosis. The relationship between the TyG index and noncalciﬁed plaque (NCP), calciﬁed or mixed plaque (CMP), and
coronary artery calcium score (CACS) was evaluated.
All participants were stratiﬁed into 4 groups based on the quartiles of the TyG index. The prevalence of CAD and obstructive CAD
signiﬁcantly increased with increasing quartiles. The risk for NCP and obstructive NCP was not different among all groups. However,
compared with group I (lowest quartile), the risk for CMPwas higher in groups III (odds ratio [OR]: 1.438) and IV (highest quartile) (OR:
1.895) (P< .05), and that for obstructive CMP was higher in groups II (OR: 1.469), III (OR: 1.595), and IV (OR: 2.168) (P< .05).
Multivariate regression analysis showed that the TyG index was associated with an increased risk for CAD (OR: 1.700), obstructive
CAD (OR: 1.692), and CACS >400 (OR: 1.448) (P< .05).
The TyG index was independently associated with the presence and severity of CAD due to an increased risk for CMP.
Abbreviations: BP = blood pressure, CACS = coronary artery calcium score, CAD = coronary artery disease, CCTA = coronary
computed tomography angiography, CI = conﬁdence interval, CMP = calciﬁed or mixed plaque, CT = computed tomography, ECG
= electrocardiogram, GFR= glomerular ﬁltration rate, HDL= high-density lipoprotein, HOMA-IR= homeostatic model assessment of
insulin resistance, IR = insulin resistance, LDL = low-density lipoprotein, NCP = noncalciﬁed plaque, OR = odds ratio, TyG =
triglyceride glucose.
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Coronary artery disease (CAD) is a major cause of morbidity and
mortality worldwide.[1] Insulin resistance (IR) has been demon-
strated to play a substantial role in the progression of coronary
atherosclerosis.[2,3] However, data on the relationship betweenEditor: Yan Li.
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1IR and coronary plaque characteristics, particularly in a relatively
healthy adult population, are limited. Recently, the triglyceride
glucose (TyG) index has been used in clinical practice as a simple
and reliable surrogate marker of IR.[4–7]
Coronary artery calcium score (CACS) is traditionally
regarded as a good marker of coronary atherosclerosis becauserogram through the National Research Foundation of Korea, funded by the
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Won et al. Medicine (2018) 97:21 Medicineit represents the degree of atheromatous plaque burden. With
the advent of imaging technology, coronary computed tomogra-
phy angiography (CCTA) has become a noninvasive tool for
evaluating coronary atherosclerosis with a high diagnostic
accuracy for detecting coronary plaques.[10–12] Thus, in the
present study, we evaluated the relationships between IR, as
assessed by the TyG index, and the presence and severity of CAD
and coronary plaque characteristics.2. Methods
2.1. Subjects and study design
This observational, retrospective study included 2840 conse-
cutive subjects with near-normal renal function (estimated
glomerular ﬁltration rate [GFR]: ≥60mL/min/1.73m2) who
underwent CCTA in a self-referral setting during a general
health check-up between January 2004 and April 2009.
Subjects were excluded from this study if they met one of
the following criteria: age <35 years; clinical history of
cardiovascular disease, cerebrovascular disease, or malignancy;
estimated GFR <60mL/min/1.73m2; or insufﬁcient medical
record for TyG index calculation. The participant’s medical
history on hypertension, diabetes, and dyslipidemia, and
smoking status were systematically collected. All blood samples
were obtained after a minimum fasting time of 8hours and
were analyzed for lipid proﬁle, including triglyceride, high-
(HDL) and low-density lipoprotein (LDL) cholesterol, and
glucose levels. The TyG index was calculated as ln (fasting
triglycerides [mg/dL] fasting glucose [mg/dL]/2).[4] The body
mass index was calculated as weight (kg)/height (m2). The
kidney function was assessed by estimated GFR using the
formula validated in the Modiﬁcation of Diet in Renal Disease
Study.[13] Hypertension was deﬁned as systolic and diastolic
blood pressures (BPs) of at least 140 and 90 mm Hg,
respectively, or those taking antihypertensive medications.
Diabetes was deﬁned as either a fasting glucose level of ≥126
mg/dL, a referral diagnosis of diabetes, or undergoing
antidiabetic treatment. Dyslipidemia was deﬁned as a total
cholesterol level of ≥240mg/dL, LDL level of ≥130mg/dL,
HDL level of 40mg/dL, triglyceride level of ≥150mg/dL, or
taking lipid-lowering medications. A participant was consid-
ered a current smoker if he/she consistently smoked or smoked
within 1 month before the study. The study protocol was
approved by the institution’s ethics committee. Because of the
retrospective nature of this study, the institutional review board
waived the need for written informed consent from study
participants.2.2. Coronary computed tomography angiography
protocol
Subjects with an initial heart rate of at least 65beats/min before
undergoing computed tomography (CT) scan were adminis-
tered a single oral dose of 50mg metoprolol tartrate (Betaloc;
Yuhan, Seoul, South Korea) 1hour before CT scan, unless the
administration of b-blockers was contraindicated. Imaging was
performed for all patients using a 64-slice CT scanner
(Sensation 64; Siemens Medical System, Forchheim, Germany).
Initially, a nonenhanced prospective electrocardiogram (ECG)-
gated scan to evaluate CACS was performed with the following
parameters: rotation time of 330ms, slice collimation of 0.6
mm, slice width of 3.0mm, tube voltage of 100 to 120kV, tube2current of 50mA, and table feed/scan of 18mm. Subsequently,
CCTA was performed using retrospective ECG gating with the
following scan parameters: rotation time of 330ms, slice
collimation of 640.6mm, tube voltage of 100 to 120kV, tube
current of 400 to 800mA (depending on the patient size), table
feed/scan of 3.8mm, and pitch factor of 0.2. ECG-based tube
current modulation was applied to 65% of the R–R interval. A
real-time bolus-tracking technique was applied to trigger scan
initiation. Contrast enhancement was achieved with 60mL
iopamidol (370mg/mL iodine, Iopamiro; Bracco, Milan, Italy)
injected at 5mL/s, followed by injection of 30mL diluted
contrast medium (saline–contrast agent ratio of 7:3), and then
30mL saline at 5mL/s with a power injector (Envision CT;
Medrad, Indianola, PA) through the antecubital vein. The
image was reconstructed using a commercially available
software (Wizard; Siemens Medical Solutions) in the scanner
workstation. The axial images were reconstructed retrospec-
tively at 65% of the R–R interval for each cardiac cycle.
Additional data sets were obtained for various points of the
cardiac cycle if artifacts were present, and the data set with the
minimum artifact was selected for further analysis. The
reconstructed image data sets were transferred to an ofﬂine
workstation (Aquarius Workstation; TeraRecon Inc., San
Mateo, CA). Each lesion identiﬁed was examined using
maximum-intensity projection and multiplanar reconstruction
techniques on a short axis and along multiple longitudinal axes.
The lesions were classiﬁed by the maximal stenosis of luminal
diameter observed on any plane.2.3. Measurement of coronary plaque and calcium
All CCTA images were evaluated by 2 experienced cardiac
radiologists. In cases of disagreement, a joint reading was
performed to reach a consensus. Plaques were deﬁned as
structures >1mm2 within and/or adjacent to the vessel lumen
that were clearly distinguishable from the lumen and surrounding
pericardial tissue. Obstructive plaques were deﬁned as plaques
with ≥50% luminal stenosis. CADwas deﬁned by the presence of
any plaques, and obstructive CADwas deﬁned by the presence of
obstructive plaques. All plaques were classiﬁed into 2 subtypes
based on the presence of coronary calciﬁcation: noncalciﬁed
plaque (NCP) and calciﬁed or mixed plaque (CMP). CACS was
evaluated based on the scoring system by using a previously
described method.[14] Severe coronary calciﬁcation was deﬁned
as CACS >400.2.4. Statistical analysis
Continuous variables were expressed as mean± standard devia-
tion. Categorical variables were presented as absolute values and
proportions. To compare the characteristics among the TyG
index groups, one-way analysis of variance was used for
continuous variables, and the x2 test or Fisher exact test was
used for categorical variables, as appropriate. Univariate logistic
regression analysis was performed to identify the risk of coronary
atherosclerotic parameters. Multivariate logistic regression
analysis was used to identify the independent determinants for
CAD, obstructive CAD, and CACS >400. The forced entry
method was used to enter independent variables into the
multivariate regression analysis. All statistical analyses were
performed using the Statistical Package for the Social Sciences
version 19 (SPSS, Chicago, IL), and P< .05 was considered
signiﬁcant for all analyses.
Table 1
Baseline characteristics.
Quartiles of the TyG index
PI (lowest) (n=711) II (n=707) III (n=711) IV (highest) (n=711)
Age, y 57±10 58±9 58±9 57±9 .268
Male, n (%) 298 (41.9) 338 (47.8) 392 (55.1) 424 (59.6) <.001
Systolic BP, mm Hg 125±14 126±14 127±14 128±15 .007
Diastolic BP, mm Hg 78±9 79±10 79±10 80±9 .001
Body mass index, kg/m2 23.6±2.8 24.6±2.8 24.8±2.8 25.1±2.6 <.001
Past history
Hypertension, n (%) 324 (46.7) 335 (48.6) 358 (51.3) 362 (52.4) .133
Diabetes mellitus, n (%) 58 (8.2) 93 (13.2) 129 (18.1) 263 (37.0) <.001
Dyslipidemia, n (%) 238 (34.0) 317 (45.6) 511 (73.2) 655 (92.9) <.001
Currently smoking, n (%) 85 (12.2) 82 (11.8) 78 (11.2) 102 (14.7) .229
Laboratory
Total cholesterol, mg/dL 179±34 185±35 189±34 195±37 <.001
Triglyceride, mg/dL 71±16 108±17 149±25 249±127 <.001
HDL cholesterol, mg/dL 58±14 52±11 48±10 45±9 <.001
LDL cholesterol, mg/dL 114±33 122±34 124±32 117±35 <.001
Fasting glucose, mg/dL 93±12 97±15 101±18 119±41 <.001
Creatinine, mg/dL 0.88±0.16 0.90±0.16 0.92±0.17 0.92±0.17 <.001
Estimated GFR 83±15 82±13 82±13 82±13 .108
TyG index 8.07±0.24 8.55±0.10 8.90±0.11 9.48±0.38 <.001
BP=blood pressure, GFR=glomerular ﬁltration rate, HDL=high-density lipoprotein, LDL= low-density lipoprotein.
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3.1. Clinical characteristics of subjects
Table 1 shows the clinical characteristics of the study
participants. All participants were stratiﬁed into 4 groups based
on their TyG index levels. Systolic and diastolic BP, body mass
index, and levels of total cholesterol, triglyceride, HDL, LDL,
fasting glucose, and creatinine were signiﬁcantly different among
the groups. No signiﬁcant difference was found in age, levels of
estimated GFR, incidence of hypertension, or smoking status.3.2. Coronary atherosclerosis based on triglyceride
glucose quartile groups
Table 2 shows the incidence of coronary atherosclerotic
parameters based on the TyG quartile groups. The incidence
of CAD and obstructive CAD signiﬁcantly increased with
increasing TyG index quartile groups. In addition, categoricalTable 2
Coronary characteristics.
Quartiles
I (lowest) (n=711) II (n=707)
CAD 269 (37.8) 307 (43.4)
NCP 46 (6.5) 54 (7.6)
CMP 223 (31.4) 253 (35.8)
Obstructive CAD 81 (11.4) 96 (13.6)
Obstructive NCP 19 (2.7) 9 (1.3)
Obstructive CMP 62 (8.7) 87 (12.3)
CACS
0 482 (67.8) 445 (62.9)
1–10 45 (6.3) 59 (8.3)
11–100 101 (14.2) 112 (15.8)
101–400 57 (8.0) 63 (8.9)
>400 26 (3.7) 28 (4.0)
CAD= coronary artery disease, CMP= calciﬁed or mixed plaque.
3CACS was signiﬁcantly different among these groups. No
signiﬁcant difference was found in the incidence of NCP (group
I [lowest quartile]: 6.5%; group II: 7.6%; group III: 8.9%; group
IV [highest quartile]: 9.3%; P= .200) or obstructive NCP (group
I: 2.7%; group II: 1.3%; group III: 2.0%; group IV: 3.1%;
P= .103) in each group. However, the incidence of CMP (group I:
31.4%; group II: 35.8%; group III: 39.7%; group IV: 46.4%;
P< .001) and obstructive CMP (group I: 8.7%; group II: 12.3%;
group III: 13.2%; group IV: 17.2%; P .001) was different
among these groups.3.3. Association between the triglyceride glucose index
and coronary atherosclerosis
Compared with group I, the risk for CAD was higher in groups II
(odds ratio [OR]: 1.261; 95% conﬁdence interval [CI]: 1.020
1.559; P= .032), III (OR: 1.549; 95%CI: 1.2541.913; P= .001)
and IV (OR: 2.06; 95% CI: 1.6712.553, P= .001), and that ofof the TyG index
III (n=711) IV (highest) (n=711) P
345 (48.5) 396 (55.7) <.001
63 (8.9) 66 (9.3) .200
282 (39.7) 330 (46.4) <.001
108 (15.2) 144 (20.3) <.001
14 (2.0) 22 (3.1) .103
94 (13.2) 122 (17.2) <.001
<.001
410 (57.7) 361 (50.8)
74 (10.4) 80 (11.3)
136 (19.1) 145 (20.4)
53 (7.5) 79 (11.1)
38 (5.3) 46 (6.5)
Figure 1. Risk of (A) CAD and (B) obstructive CAD based on the triglyceride glucose (TyG) index group. CAD=coronary artery disease, CI=conﬁdence interval,
OR=odds ratio.
Won et al. Medicine (2018) 97:21 Medicineobstructive CAD was higher in groups III (OR: 1.393; 95% CI:
1.0231.897; P= .035) and IV (OR: 1.975; 95% CI:
1.4712.653; P= .001) (Fig. 1). The risk for developing NCP
and obstructive NCP was not signiﬁcantly different among the
groups. However, compared with group I, the risk for CMP was
higher in groups III (OR: 1.438; 95%CI: 1.1561.790; P= .001)
and IV (OR: 1.895; 95%CI: 1.5272.353; P= .001), and that of
obstructive CMP was higher in groups II (OR: 1.469; 95% CI:
1.0412.072; P= .028), III (OR: 1.595, 95% CI: 1.1362.238;Figure 2. Relationship of the triglyceride glucose (TyG) index and subtypes of coron
CI=conﬁdence interval, CMP=calciﬁed or mixed plaque, NCP=noncalciﬁed plaq
4P= .007), and IV (OR: 2.168, 95% CI: 1.5663.002; P= .001)
(Fig. 2).
3.4. Impact of clinical variables on coronary
atherosclerosis
Table 3 shows the results of the multivariate regression analysis
to identify the relationship between traditional metabolic risk
factors and the presence and severity of CAD and severe coronaryary plaque as (A) NCP, (B) CMP, (C) obstructive NCP, and (D) obstructive CMP.
ue, OR=odds ratio.
Table 3
Association between clinical variables and coronary atherosclerotic parameters.
CAD Obstructive CAD CACS >400
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Age, y 1.099 (1.087–1.112) <.001 1.067 (1.052–1.081) <.001 1.101 (1.074–1.128) <.001
Male 2.722 (2.252–3.289) <.001 2.375 (1.843–3.060) <.001 2.204 (1.437–3.380) <.001
Body mass index ≥25 kg/m2 1.230 (1.030–1.470) .022 1.039 (0.821–1.314) .750 0.848 (0.566–1.270) .424
Increased BP 1.157 (0.952–1.407) .143 1.227 (0.937–1.608) .137 1.699 (1.027–2.810) .039
HDL <40 mg/dL 1.028 (0.837–1.261) .794 1.281 (0.984–1.667) .066 1.383 (0.896–2.135) .144
LDL >130 mg/dL 1.171 (0.977–1.403) .088 0.968 (0.758–1.236) .793 0.598 (0.378–0.946) .028
Currently smoking 0.790 (0.603–1.034) .086 1.002 (0.706–1.422) .990 1.273 (0.725–2.237) .401
TyG index 1.700 (1.436–2.013) <.001 1.692 (1.371–2.088) <.001 1.448 (1.028–2.039) .034
BP=blood pressure, CACS=coronary artery calcium score, CAD=coronary artery disease, HDL=high-density lipoprotein, LDL= low-density lipoprotein.
Won et al. Medicine (2018) 97:21 www.md-journal.comcalciﬁcation. Age (OR: 1.099; 95% CI: 1.087–1.112; P< .001),
male sex (OR: 2.722; 95% CI: 2.252–3.289; P< .001), body
mass index (OR: 1.230; 95% CI: 1.030–1.470; P= .022), and
TyG index (OR: 1.700; 95% CI: 1.436–2.013; P< .001) were
associated with an increased risk for CAD. In addition, age (OR:
1.067; 95% CI: 1.052–1.081; P< .001), male sex (OR: 2.375;
95% CI: 1.843–3.060; P< .001), and TyG index (OR: 1.692;
95% CI: 1.371–2.088; P< .001) were associated with an
increased risk for obstructive CAD. Furthermore, age (OR:
1.101; 95% CI: 1.074–1.128; P< .001), male sex (OR: 2.204;
95% CI: 1.437–3.380; P< .001), increased BP (OR: 1.699; 95%
CI: 1.027–2.810; P= .039), LDL >130mg/dL (OR: 0.598; 95%
CI: 0.378–0.946; P= .028), and TyG index (OR: 1.448; 95% CI:
1.028–2.039; P= .034) were associated with CACS >400.4. Discussion
The primary ﬁndings of the present study were that the TyG
index was associated with the presence of CAD, obstructive
CAD, and severe coronary calciﬁcation after adjusting for
confounding factors. These results were related to the increased
risk for developing CMP and obstructive CMP with increasing
TyG index.
IR has been well known to play a pivotal role for metabolic
disorders.[15] The homeostatic model assessment of IR (HOMA-
IR) has been traditionally used to measure IR.[16,17] However, the
measurement of insulin levels is necessary for calculating the
HOMA-IR. Because insulin levels are not usually measured
during general health check-up in South Korea, calculating the
HOMA-IR to estimate IR is an inconvenient method for this
population. Recently, several studies reported that the TyG index
is closely correlated with the HOMA-IR.[18,19] Moreover,
some studies showed that the predictive value of the TyG index
for IR is better than that of the HOMA-IR.[6,20] Thus, the TyG
index is being considered as a simple surrogate marker of IR for
clinical practice.
A number of studies have suggested the signiﬁcance of IR in the
development of CAD. Hanley et al[21] reported an independent
association between the HOMA-IR and risk for CAD in the San
Antonio Heart Study. The Bruneck study also revealed that IR is
associated with subsequent symptomatic CAD independent of
traditional risk factors in the general population.[2] Eddy et al[3]
emphasized that IR is the single most common cause of CAD by
using the Archimedes model of diabetic dyslipidemia. However,
data on the relationship between IR and coronary atherosclerosis
characteristics in the general population are scarce. Recently, Kim
et al[22] reported that the TyG index was independently5associated with CACS in a healthy adult population. Interesting-
ly, they identiﬁed that the TyG index was more independently
associated with the presence of coronary artery calcium than the
HOMA-IR. However, this study was limited because only CACS
was used as a coronary atherosclerotic parameter.
CCTA is a useful and noninvasive tool for the evaluation of
coronary atherosclerosis. In the present study, we identiﬁed
that the TyG index is independently associated with the
presence and severity of CAD and severe coronary calciﬁcation
by using CCTA. One result worth noting is that the risk for
developing NCP and obstructive NCP was not signiﬁcantly
affected by the TyG index. Considering the substantial impact
of diabetes on coronary calciﬁcation, these results may be
associated with the increased prevalence of diabetes with
increasing TyG index.[23] One important mechanism might be
hyperglycemic damage which activates endothelial dysfunction
and vascular inﬂammation. Also, hyperglycemia increases
oxidative stress by stimulating glucose oxidation.[24] A
previous observational study reported that CACS could be
an effective gatekeeper to evaluate obstructive CAD by using
CCTA in asymptomatic subjects with established diabetes
because obstructive NCP was hardly observed in those
subjects.[25] The results of the present study were consistent
with those of previous investigations and may imply that IR
strongly inﬂuences the progression of coronary plaque with
concomitant coronary calciﬁcation.
The present study has some limitations. First, it used a
retrospective design based on the healthy population who
underwent a general health check-up. Thus, the results may
have been inﬂuenced by unobserved confounders or potential
selection biases. Second, we could not eliminate the possible
effects of the medications on CAD because of the observational
design. Third, we did not measure the HOMA-IR because the
examination of insulin levels is not typically included in general
health check-up at our institution. However, the close relation-
ship between the TyG index and HOMA-IR was already well-
established, as previously described. Finally, we did not
investigate the association between the TyG index and adverse
plaque characteristics, such as low plaque attenuation, positive
remodeling, and spotty calciﬁcation.[26,27] Further large-scale
prospective investigations may be necessary to identify the impact
of IR on coronary plaque vulnerability.
In conclusion, the TyG index is signiﬁcantly associatedwith the
presence and severity of CAD and severe coronary calciﬁcation
after adjusting for confounding factors. These results are
associated with the increased risk for CMP with increasing
TyG index.
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